Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Planning for the future? Find effective ways to save for future goals and ensure you reach your financial aspirations.
17,671 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
The Pentagon has formally designated Anthropic as a supply chain risk, a move that could curtail access to defense co...
ExxonMobil and Chevron are rallying as investors price in a richer oil regime, with big-cap budgets and buyback plans...
One year after the pledge, the Strategic Petroleum Reserve remains short of full capacity while crude prices push pas...
The FAA unveiled an eight-project pilot program to test electric takeoff-and-landing aircraft in 26 states, signaling...
TMC jumped on regulatory news, but the road to deep-seabed mining remains lengthy and costly. This guide breaks down ...
A newly released inspector general report into a Bridgeport shooting finds the pursuit justified but highlights ambul...
A look at five 2016 IPOs shows how a $1,000 investment in each would have fared through 2026, highlighting divergent ...
Top multifamily owners don’t wait for year-end reports. They review a concise set of metrics every quarter to steer l...
A reporter documenting a geopolitics-driven forecast market linked to a $14 million pool received direct threats, pro...
Carvana’s pivot from pure online disruption to owning physical dealerships is surprising. This piece breaks down why ...
Geopolitics can push oil to $100 a barrel, but certain pipeline stocks thrive on throughput rather than price. Learn ...